The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 02, 2008
Filed:
Dec. 17, 2001
Pia M. Challita-eid, Encino, CA (US);
Mary Faris, Los Angeles, CA (US);
Daniel E. H. Afar, Brisbane, CA (US);
Rene S. Hubert, Los Angeles, CA (US);
Steve Chappell Mitchell, Gurnee, IL (US);
Elana Levin, Los Angeles, CA (US);
Karen Jane Meyrick Morrison, Santa Monica, CA (US);
Arthur B. Raitano, Los Angeles, CA (US);
Aya Jakobovits, Beverly Hills, CA (US);
Pia M. Challita-Eid, Encino, CA (US);
Mary Faris, Los Angeles, CA (US);
Daniel E. H. Afar, Brisbane, CA (US);
Rene S. Hubert, Los Angeles, CA (US);
Steve Chappell Mitchell, Gurnee, IL (US);
Elana Levin, Los Angeles, CA (US);
Karen Jane Meyrick Morrison, Santa Monica, CA (US);
Arthur B. Raitano, Los Angeles, CA (US);
Aya Jakobovits, Beverly Hills, CA (US);
Agensys, Inc., Santa Monica, CA (US);
Abstract
A novel gene (designated 108P5H8) and its encoded protein, and variants thereof, are described wherein 108P5H8 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 108P5H8 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 108P5H8 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 191P1E1B can be used in active or passive immunization.